129 related articles for article (PubMed ID: 7504717)
1. Evaluation of hyperechoic liver tumors in MHTS.
Kimura Y; Fukada R; Katagiri S; Matsuda Y
J Med Syst; 1993 Aug; 17(3-4):127-32. PubMed ID: 7504717
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: the diagnostic difficulties of ultrasonography and analysis of risk factors in MHTS.
Sekiguchi R; Kuwajima A; Nagamoto M; Ohno H; Tamura M
J Med Syst; 1993 Aug; 17(3-4):133-7. PubMed ID: 7504718
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma.
Ren FY; Piao XX; Jin AL
World J Gastroenterol; 2006 Aug; 12(29):4656-9. PubMed ID: 16937435
[TBL] [Abstract][Full Text] [Related]
4. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
5. [Liver tumor as incidental ultrasound finding].
Görtz RS; Strobel D
MMW Fortschr Med; 2010 Jan; 152(3):41-3. PubMed ID: 20333967
[No Abstract] [Full Text] [Related]
6. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
[TBL] [Abstract][Full Text] [Related]
7. Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
van Staden L; Bukofzer S; Kew MC; Savage N
J Gastroenterol Hepatol; 1992; 7(3):260-5. PubMed ID: 1377039
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
Giannini EG; Farinati F; Trevisani F
Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
[No Abstract] [Full Text] [Related]
9. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
10. Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent.
Chen LT; Shiah HS; Chao Y; Chang JY; Cheng LT; Whang-Peng J
J Clin Oncol; 2009 Dec; 27(36):e271; author reply e272. PubMed ID: 19917866
[No Abstract] [Full Text] [Related]
11. Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients.
Caturelli E; Pompili M; Bartolucci F; Siena DA; Sperandeo M; Andriulli A; Bisceglia M
Radiology; 2001 Aug; 220(2):337-42. PubMed ID: 11477234
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
13. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
[TBL] [Abstract][Full Text] [Related]
14. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
Abbasi A; Bhutto AR; Butt N; Munir SM
J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
[TBL] [Abstract][Full Text] [Related]
15. Did AFP-L3 save ultrasonography in community screening?
Yen CW; Kuo YH; Wang JH; Chang KC; Kee KM; Hung SF; Chen Y; Tsai LS; Chen SC; Hung CH; Lu SN
Kaohsiung J Med Sci; 2018 Oct; 34(10):583-587. PubMed ID: 30309487
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of a hepatic hyper-echogenic image in 1990].
Bili H; Foll Y; Boyer B; Abgrall J
Ann Gastroenterol Hepatol (Paris); 1990 Oct; 26(5):203-8. PubMed ID: 2175158
[No Abstract] [Full Text] [Related]
17. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction.
Aoyagi Y; Tamura Y; Suda T
J Gastroenterol Hepatol; 2011 Apr; 26(4):615-6. PubMed ID: 21418297
[No Abstract] [Full Text] [Related]
18. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
Hadziyannis E; Sialevris K; Georgiou A; Koskinas J
Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906
[TBL] [Abstract][Full Text] [Related]
19. Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.
Kuromatsu R; Tanaka M; Tanikawa K
Liver; 1993 Aug; 13(4):177-82. PubMed ID: 7690873
[TBL] [Abstract][Full Text] [Related]
20. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma.
Gad A; Tanaka E; Matsumoto A; Wahab MA; Serwah Ael-H; Attia F; Ali K; Hassouba H; el-Deeb Ael-R; Ichijyo T; Umemura T; Muto H; Yoshizawa K; Kiyosawa K
World J Gastroenterol; 2005 Nov; 11(42):6607-12. PubMed ID: 16425352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
